This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers at the Indian Institute of Science (IISc) have found that picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses. The Institute is now looking for partners in pharmacompanies to pursue further clinical development of the findings.
Indian healthcare providers and pharmacompanies pace up their efforts with early detection and research for new medicines to combat the spread of tuberculosis as drug resistance concerns emerge. TB is a significant public health threat, with an estimated 10 million annual cases. India shares the highest TB burden with 2.69
As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinicalresearch. This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinicalresearch industry. .
Data is readily shared and leveraged for decision-makers to gain insight that can help clinicalresearch. Jessica Hagen is a freelance life sciences and health writer and project manager who has worked with VR health companies, fiction/nonfiction authors, nonprofit and for-profit organisations, and government entities.
The Department of Pharmaceuticals (DoP) has issued a new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, permitting pharmacompanies to provide brand reminders such as informational and education items and free samples to medical professionals with restrictions on sample packs and total value.
The pharmacompanies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.
Indian pharma sees immense value in US FDA’s insistence for aluminum content and labelling recommendations for the Small Volume Parenterals Drug Products and Pharmacy Bulk Packages. Pharmacompanies in the country have increasingly made a shift to nutritional based prescription and over the counter products.
The Delhi High Court has granted ten days’ time to the Government of India and the nation’s drug regulator to file a counter affidavit on the petitions filed by almost 28 pharmacompanies against the order prohibiting manufacturing, distribution and sale of 14 FDCs licensed prior to the year 1988, in the beginning of June. […]
This is partly due to the differing business models used by pharmacompanies and digital therapeutic developers. To do that, the company would need to do clinicalresearch that features both therapies, he adds. Securing reimbursement for digital therapeutics also continues to impede its uptake.
The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharmacompanies. The company was selected for its industry leading Virtual Care Management (VCM) program.
EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharmacompanies. But the EU draft document says that the changes will make medicines more affordable, improve unequal access to medicines across the EU, and fulfil unmet patient needs.
Pharmacompanies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. The NIHR is also embedded in the NHS, perhaps the most trusted institution in the UK.
In recent years the retail pharmacy chain has begun to delve more and more deeply into the healthcare sector – by constantly expanding the basic healthcare services offered at their instore Minute Clinics, and by buying into the health insurance insurance space with their $69 billion purchase of Aetna in 2017. JR: Let’s flip it.
In the UK, research organisations and pharmacompanies are working to find ways to reach this goal, using data to inform commercial clinicalresearch now, and how this foundation can be built upon in the future. The current data landscape in commercial clinicalresearch.
That was the message from ‘The New Normal: Balancing the rapid evolution of trial design with patient need’ panel at the NIHR’s ClinicalResearch Network Virtual Event on Delivering Complex and Innovative Design (CID) Studies. Thankfully, many pharmacompanies seem to be gradually improving on this. Listening to patients.
Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharmacompanies can help make patient involvement in HTA more impactful. The earlier HTAs, researchers and pharmacompanies can start that engagement the better.
deVries co-founded Medidata in 1999 as a provider of technological software solutions to advance clinicalresearch. Dassault Systèmes acquired the company in 2019 and de Vries was serving as the Life Sciences & Healthcare vice-chair for the new parent company.
It’s been developed in collaboration with pharmacompanies to offer a way to incorporate EEG testing in clinical trials much more easily than at present, with the opportunity to harvest much more data over time.
Across the industry, pharmacompanies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
A group representing pharmacompanies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs.
The arrival of COVID-19 meant that certain virtual technologies became essential for clinical trials to continue, bringing certain activities into the patient’s home and allowing for further activities to be conducted remotely. The post Decentralised trials: beyond the pandemic appeared first on.
. “The cost of developing a new drug is extortionately high,” said Landray, adding that a very large proportion of those costs is in phase 3, and that means many promising therapies may never be taken forward by pharmacompanies.
The annual peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma highlights companies that have demonstrated innovative solutions, technologies, and services and have the potential to make the greatest impact for biotech and pharmacompanies.?. 2020 Accolades. 2018 & 2019 Achievements.
Soon the ABPI and the entire industry were facing the ripple effects of COVID-19, including a significant slowdown in non-COVID clinicalresearch, which Torbett says was challenging for the industry to deal with. “We’ve “It’s been a very interesting year to kick things off.”. A collaborative future.
Individuals looking to start, or further their careers in clinicalresearch can benefit from the inside look that experts from Syneos will provide in the webinar. This will help job seekers learn more about specific positions and the industry as a whole.
The adoption of digital healthcare tools in clinicalresearch accelerated dramatically during the COVID-19 pandemic and it is expected that such tools will continue to contribute to clinicalresearch in the future. What comes next?
Ben Hargreaves discovers why medical research in the area has shifted from being highly controversial to being backed by major pharmacompanies and venture capital. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.
This philosophy was behind Xperiome’s recent decision to split into two different functions – Raremark, a community where patients and carers can share their experiences of living with rare diseases, and Xperiome, which leverages those insights for pharmacompanies looking to develop drugs for these conditions.
There was a genuine sense of alliance; regulatory bodies and pharmacompanies coming together to accelerate processes and find the most optimal model for collaboration. Quantifying the use of connected digital products in clinicalresearch. When the COVID-19 pandemic hit, it lit a fire under the regulatory system.
Collaboration in clinicalresearch. The last 18 months have seen some incredible scientific leaps directly tackling the pandemic, brought about by unprecedented alliances seen between pharmacompanies and between academia and pharma. As we look to the future, collaboration is key on many levels.
Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. Pharmacompanies need tools like AI that can reliably improve this percentage without jeopardizing safety. Learn more about the benefits and challenges of AI and clinical trials, as well as examples of AI’s use in this industry.
Time is also of the essence in drug development, as competitive product-to-market lead times help pharmacompanies improve profitability. Time spent on clinical trials involves investment and being able to predict ADRs assists with improving the success rate. Navro Technology Solutions – AI-Based Pharmacovigilance.
Verily is also looking to accelerate a number of its key businesses, with the company calling out clinicalresearch ecosystem Baseline, COVID-19 testing platform Healthy at Work and virtual clinic Onduo. Meanwhile, the last 12 months have seen a refocusing at Onduo.
Beyond digital clinical measures, digital solutions are maturing to address major challenges facing clinicalresearch and offer enormous promise to support the key performance indicators (KPIs) for every member of our industry. Pharmacompanies with more mature digital strategies are able to focus on questions of scale.
. “We are already making an impact for our customers and for medical research, by raising patient trust and engagement in their care,” he continued, pointing to ongoing relationships with a wide range of study partners, including clinicalresearch organisations, pharmacompanies, and academic medical centres.
We take a look at efforts from charities, the government and digital innovators to boost awareness of rare conditions among GPs and make the clinical pathway smoother for patients. Inside the UK’s leading efforts to restart clinicalresearch. Centessa’s founder on the new company’s unique R&D model.
But, with a growing number of cancer treatments entering the market each year and dedicated research efforts driving innovation in the sector, there are positive signs that the industry is on the right track. Diversity is no longer an optional luxury in clinicalresearch, explain Dr Stephen Keith and Nick Kenny from Syneos.
Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharmacompanies, and gives tips for companies navigating this enormous market. Dr Jay Mei has nearly 30 years of experience in clinicalresearch and development of oncology therapeutics globally. About the interviewee.
The ‘PEP Talks’ monthly e-newsletter has approaching 50 pharmacompanies as subscribers and the inaugural ‘Patient Engagement Day’ on September 01 st achieved an inspirational number of downloads of toolkits for ways to ‘Amplify the Patient Voice’ as the launch theme.
They include mistrust of the clinicalresearch system, unfeasible trial design, and time and resource constraints. An increase in pharma organisations seeking patient input, however, is bound to place additional pressure on already-stretched patient advocacy groups, said Ellen Coleman, president and CEO of VOZ Advisors. “Is
While randomised clinical trials remain the gold standard for testing medicines, showing how they perform in real-world settings is gaining increasing importance for both regulators and payers. Eversana push into RWD gathered momentum last year when it launched a data management and analysis platform for chronic diseases.
Data-Driven Personalization : Using real-time insights, pharmacompanies can deliver tailored content to physicians and patients. However, pharma marketers must navigate strict compliance regulations to avoid misleading advertising or privacy violations. How do pharma brands ensure compliance in digital advertising?
Data-Driven Personalization : Using real-time insights, pharmacompanies can deliver tailored content to physicians and patients. However, pharma marketers must navigate strict compliance regulations to avoid misleading advertising or privacy violations. How do pharma brands ensure compliance in digital advertising?
Pharmacompanies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. That is what’s exciting – as we see DCTs continue to play such a key role that they become the standard for the future of clinicalresearch,” predicts Reites.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
189 
Let's personalize your content